• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TLR2、TLR3、TLR4和CD14基因多态性与口腔癌风险及生存的关联

Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival.

作者信息

Zeljic K, Supic G, Jovic N, Kozomara R, Brankovic-Magic M, Obrenovic M, Magic Z

机构信息

Institute for Medical Research, Military Medical Academy, Belgrade, Serbia; Faculty of Biology, University of Belgrade, Belgrade, Serbia.

出版信息

Oral Dis. 2014 May;20(4):416-24. doi: 10.1111/odi.12144. Epub 2013 Jun 24.

DOI:10.1111/odi.12144
PMID:23796347
Abstract

OBJECTIVES

The aim of this study is to investigate association between polymorphisms in TLR2, TLR3, TLR4 and CD14 genes or their haplotypes with oral squamous cell carcinomas (OSCC) risk and survival.

METHODS

The study was conducted on 93 OSCC patients and 104 cancer-free controls. Polymorphisms were genotyped by real-time PCR or PCR-RFLP method.

RESULTS

Significant increase in oral cancer risk was observed in individuals with mutated genotype of TLR3 rs3775291 polymorphism (OR = 1.096, P = 0.036) compared to wild-type. The heterozygous and mutated genotype of TLR3 rs5743312 polymorphism had worse survival in group of patients with stage III tumours (P = 0.043). Multivariate Cox regression analysis revealed that TLR3 rs5743312 polymorphism could be considered as prognostic marker in advanced III stage OSCC (HR = 2.456, P = 0.007), but not independently of nodal status. TLR3 rs3775291 and rs5743312 polymorphisms were in strong linkage disequilibrium. Haplotype TG was associated with worse prognosis in OSCC patients in comparison with common CG haplotype (HR = 1.717, P = 0.042). Interaction among polymorphisms in TLR2, TLR3 and CD14 genes was observed (P = 0.010).

CONCLUSIONS

TLR3 rs5743312 polymorphism could be considered as potential predictor of worse overall survival in advanced oral cancer, but not independently of nodal status. Haplotypes in TLR3 gene might be associated with poor prognosis in OSCC patients.

摘要

目的

本研究旨在调查Toll样受体2(TLR2)、Toll样受体3(TLR3)、Toll样受体4(TLR4)和CD14基因的多态性或其单倍型与口腔鳞状细胞癌(OSCC)风险及生存之间的关联。

方法

对93例OSCC患者和104例无癌对照者进行研究。采用实时聚合酶链反应(PCR)或聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法对多态性进行基因分型。

结果

与野生型相比,TLR3 rs3775291多态性突变基因型个体的口腔癌风险显著增加(比值比[OR]=1.096,P=0.036)。TLR3 rs5743312多态性的杂合子和突变基因型在Ⅲ期肿瘤患者组中生存较差(P=0.043)。多因素Cox回归分析显示,TLR3 rs5743312多态性可被视为晚期Ⅲ期OSCC的预后标志物(风险比[HR]=2.456,P=0.007),但不独立于淋巴结状态。TLR3 rs3775291和rs5743312多态性处于强连锁不平衡状态。与常见的CG单倍型相比,单倍型TG与OSCC患者的预后较差相关(HR=1.717,P=0.042)。观察到TLR2、TLR3和CD14基因多态性之间存在相互作用(P=0.010)。

结论

TLR3 rs5743312多态性可被视为晚期口腔癌总体生存较差的潜在预测指标,但不独立于淋巴结状态。TLR3基因的单倍型可能与OSCC患者的预后不良相关。

相似文献

1
Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival.TLR2、TLR3、TLR4和CD14基因多态性与口腔癌风险及生存的关联
Oral Dis. 2014 May;20(4):416-24. doi: 10.1111/odi.12144. Epub 2013 Jun 24.
2
TLR2, TLR3, TLR4 and CD14 gene polymorphisms associated with oral lichen planus risk.与口腔扁平苔藓风险相关的Toll样受体2、Toll样受体3、Toll样受体4和CD14基因多态性
Eur J Oral Sci. 2013 Oct;121(5):421-6. doi: 10.1111/eos.12074. Epub 2013 Aug 9.
3
Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients.血管内皮生长因子 A 基因多态性与晚期口腔鳞状细胞癌患者的癌症风险和生存的相关性。
Oral Oncol. 2012 Nov;48(11):1171-7. doi: 10.1016/j.oraloncology.2012.05.023. Epub 2012 Jul 18.
4
Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation.TLR4/CD14和TLR3基因多态性对肾移植急性排斥反应的影响。
Transplantation. 2009 Sep 15;88(5):699-705. doi: 10.1097/TP.0b013e3181b2f34a.
5
Atopy and new-onset asthma in young Danish farmers and CD14, TLR2, and TLR4 genetic polymorphisms: a nested case-control study.丹麦年轻农民的特应性和新发哮喘与CD14、TLR2和TLR4基因多态性:一项巢式病例对照研究。
Clin Exp Allergy. 2007 Nov;37(11):1602-8. doi: 10.1111/j.1365-2222.2007.02831.x. Epub 2007 Sep 17.
6
Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.Toll样受体在突尼斯女性宫颈癌易感性中的作用。
Bull Cancer. 2014 Oct;101(10):E31-5. doi: 10.1684/bdc.2014.2037.
7
Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer.幽门螺杆菌感染及相关胃癌中Toll样受体信号通路的基因多态性
Hum Immunol. 2014 Aug;75(8):808-15. doi: 10.1016/j.humimm.2014.06.001. Epub 2014 Jun 11.
8
Toll-like receptor 2 rs4696480 polymorphism and risk of oral cancer and oral potentially malignant disorder.Toll 样受体 2 rs4696480 多态性与口腔癌和口腔潜在恶性疾病的风险。
Arch Oral Biol. 2017 Oct;82:109-114. doi: 10.1016/j.archoralbio.2017.06.003. Epub 2017 Jun 6.
9
Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma.血管内皮生长因子基因单核苷酸多态性与口腔鳞状细胞癌长期预后的关系。
J Oral Pathol Med. 2013 May;42(5):374-81. doi: 10.1111/jop.12026. Epub 2012 Dec 10.
10
Polymorphisms in toll-like receptor 3 and 4 genes as prognostic and outcome biomarkers in melanoma patients.Toll 样受体 3 和 4 基因多态性作为黑色素瘤患者的预后和结局生物标志物。
Melanoma Res. 2022 Oct 1;32(5):309-317. doi: 10.1097/CMR.0000000000000836. Epub 2022 Jul 19.

引用本文的文献

1
Involvement of nucleic acid-sensing toll-like receptors in human diseases and their controlling mechanisms.核酸传感Toll样受体在人类疾病中的作用及其调控机制。
J Biomed Sci. 2025 Jun 10;32(1):56. doi: 10.1186/s12929-025-01151-9.
2
Role of N6-methyladenosine methylation in head and neck cancer and its regulation of innate immune pathways.N6-甲基腺苷甲基化在头颈部癌症中的作用及其对固有免疫途径的调控。
Front Immunol. 2024 Sep 30;15:1458884. doi: 10.3389/fimmu.2024.1458884. eCollection 2024.
3
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy.
结直肠癌特异性 IFNβ 递呈克服了功能失调的 dsRNA 介导的 I 型干扰素信号转导,从而增加了放射治疗的远隔效应。
J Immunother Cancer. 2024 May 15;12(5):e008515. doi: 10.1136/jitc-2023-008515.
4
Expression of Toll-like receptors in oral squamous cell carcinoma.Toll 样受体在口腔鳞状细胞癌中的表达。
PLoS One. 2024 Apr 9;19(4):e0300437. doi: 10.1371/journal.pone.0300437. eCollection 2024.
5
Role of toll-like receptor in the pathogenesis of oral cancer.Toll 样受体在口腔癌发病机制中的作用。
Cell Biochem Biophys. 2024 Mar;82(1):91-105. doi: 10.1007/s12013-023-01191-8. Epub 2023 Oct 19.
6
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. Toll 样受体导向的人类癌症治疗干预:分子和免疫学观点。
Front Immunol. 2023 Sep 26;14:1244345. doi: 10.3389/fimmu.2023.1244345. eCollection 2023.
7
The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas.Toll样受体3(TLR3)L412F多态性可阻止小儿肉瘤中TLR3介导的肿瘤细胞死亡诱导。
Cell Death Discov. 2023 Jul 7;9(1):230. doi: 10.1038/s41420-023-01513-y.
8
Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities.Toll样受体与实体瘤放疗反应:挑战与机遇
Vaccines (Basel). 2023 Apr 7;11(4):818. doi: 10.3390/vaccines11040818.
9
Association of TLR4 gene 2026A/G (rs1927914), 896A/G (rs4986790), and 1196C/T (rs4986791) polymorphisms and cancer susceptibility: Meta-analysis and trial sequential analysis.TLR4 基因 2026A/G(rs1927914)、896A/G(rs4986790)和 1196C/T(rs4986791)多态性与癌症易感性的关联:Meta 分析和试验序贯分析。
Medicine (Baltimore). 2023 Feb 22;102(8):e33040. doi: 10.1097/MD.0000000000033040.
10
Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer.树突状细胞:在癌症中成功靶向的漫长而曲折的道路。
Cells. 2022 Sep 27;11(19):3028. doi: 10.3390/cells11193028.